Therapeutic Potential of Sea Cucumber-Derived Bioactives in the Prevention and Management of Brain-Related Disorders: A Comprehensive Review.

Fuente: PubMed
Enregistré dans:
Détails bibliographiques
Auteurs principaux: Debi, Purnima Rani, Barua, Hrishika, Ahmmed, Mirja Kaizer, Bhowmik, Shuva
Format: Artículo científico
Langue:en
Publié: Marine drugs 2025
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1868266160097591299
author Debi, Purnima Rani
Barua, Hrishika
Ahmmed, Mirja Kaizer
Bhowmik, Shuva
author_facet Debi, Purnima Rani
Barua, Hrishika
Ahmmed, Mirja Kaizer
Bhowmik, Shuva
Debi, Purnima Rani
Barua, Hrishika
Ahmmed, Mirja Kaizer
Bhowmik, Shuva
collection PubMed - marine biology
contents Therapeutic Potential of Sea Cucumber-Derived Bioactives in the Prevention and Management of Brain-Related Disorders: A Comprehensive Review. Debi, Purnima Rani Barua, Hrishika Ahmmed, Mirja Kaizer Bhowmik, Shuva Humans Sea Cucumbers Animals Neuroprotective Agents Neurodegenerative Diseases Brain Diseases Biological Products The popularity of bioactive compounds extracted from sea cucumbers is growing due to their wide application in the pharmaceutical industry, particularly in the development of drugs for neurological disorders. Different types of compounds, such as saponins, phenolic compounds, cerebrosides, and glucocerebrosides, are being studied intensively for their efficacy in assessing the treatment of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and brain tumors, among others. Positive results have been observed in the upregulation in the content of p-CREB, p-PL3K, BDNF, SOD, and MDA. Furthermore, the neuroprotective mechanism of the compounds against Alzheimer's disease revealed that suppressing the phosphorylation of tau protein by the PI3K/Akt/GSK3β pathway leads to improved synaptic plasticity and reduced nerve fiber tangles. This comprehensive review explores recent findings on the therapeutic potential of sea cucumber bioactives in the treatment of brain-related disorders.
format Artículo científico
id pubmed_40863627
institution PubMed
language en
publishDate 2025
publisher Marine drugs
record_format pubmed
spellingShingle Therapeutic Potential of Sea Cucumber-Derived Bioactives in the Prevention and Management of Brain-Related Disorders: A Comprehensive Review.
Debi, Purnima Rani
Barua, Hrishika
Ahmmed, Mirja Kaizer
Bhowmik, Shuva
Humans
Sea Cucumbers
Animals
Neuroprotective Agents
Neurodegenerative Diseases
Brain Diseases
Biological Products
Therapeutic Potential of Sea Cucumber-Derived Bioactives in the Prevention and Management of Brain-Related Disorders: A Comprehensive Review. Debi, Purnima Rani Barua, Hrishika Ahmmed, Mirja Kaizer Bhowmik, Shuva Humans Sea Cucumbers Animals Neuroprotective Agents Neurodegenerative Diseases Brain Diseases Biological Products The popularity of bioactive compounds extracted from sea cucumbers is growing due to their wide application in the pharmaceutical industry, particularly in the development of drugs for neurological disorders. Different types of compounds, such as saponins, phenolic compounds, cerebrosides, and glucocerebrosides, are being studied intensively for their efficacy in assessing the treatment of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and brain tumors, among others. Positive results have been observed in the upregulation in the content of p-CREB, p-PL3K, BDNF, SOD, and MDA. Furthermore, the neuroprotective mechanism of the compounds against Alzheimer's disease revealed that suppressing the phosphorylation of tau protein by the PI3K/Akt/GSK3β pathway leads to improved synaptic plasticity and reduced nerve fiber tangles. This comprehensive review explores recent findings on the therapeutic potential of sea cucumber bioactives in the treatment of brain-related disorders.
title Therapeutic Potential of Sea Cucumber-Derived Bioactives in the Prevention and Management of Brain-Related Disorders: A Comprehensive Review.
topic Humans
Sea Cucumbers
Animals
Neuroprotective Agents
Neurodegenerative Diseases
Brain Diseases
Biological Products
url https://pubmed.ncbi.nlm.nih.gov/40863627/